Please login to the form below
Philip Morris International
This page shows the latest Philip Morris International news and features for those working in and with pharma, biotech and healthcare.
Vectura board backs Philip Morris takeover bid over The Carlyle Group offer
The board plans to unanimously recommend the $1.5bn bid from Philip Morris to shareholders. ... Following last week’s report of the bidding war between British tobacco giant Philip Morris International (PMI) and US private equity firm The Carlyle Group,
Latest news
-
British officials reportedly monitoring Philip Morris’ proposed acquisition of Vectura
British officials are reportedly monitoring tobacco company Philip Morris International’s (PMI) proposed acquisition of inhaled-drug company Vectura, according to The Times.
-
Philip Morris International to acquire inhaled drug company Vectura for $1.2bn
Multinational cigarette and tobacco manufacturing company Philip Morris International has announced a deal to acquire UK-headquartered inhaled-drug company Vectura for $1.2 bn. ... Philip Morris International (PMI), which owns a number of cigarette
-
ABPI and Luther Pendragon parted ways over tobacco lobbying
packaging [of tobacco products] on behalf of Philip Morris". ... This showed a list of Luther Pendragon's clients between 1 September 2012 and 30 November 2012, which included both the pharma body and Philip Morris International.
More from news
Approximately 3 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
Onyx Health Announces a "Double Hatrick" of New Appointments
She has a wealth of expertise in medical communication and serves on various international advisory boards for healthcare-related issues. ... She has previously helped deliver a global recruitment programme for Shell, as well as award-winning campaigns
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Principal Medical Writer/ Scientific Lead, Medcomms, £5K joining...
-
Highly competitive salary
- Lead Market Access Writer, £5K joining bonus, UK
-
Highly competitive salary
- Exciting Medical Writer Career Opportunity for Postdoc, Medcomms
-
Highly competitive salary
- Market Access Director, six figure base salary and £5K joining b...
-
Highly competitive salary
- World Health Organization releases latest set of COVID-19 guidelines
- BeiGene’s Brukinsa receives FDA approval for chronic lymphocytic leukaemia
- AstraZeneca/Daiichi Sankyo’s Enhertu approved by EC for advanced breast cancer
- Eli Lilly announces $450m investment in US manufacturing site
- Europe’s cancer community publishes new report on transforming patient care
- EU outlines measures to mitigate antibiotic shortage across Europe
- Innovative Trials comments on extra funding to increase access to clinical trials for cancer patients
- Gilead’s CAR-T cell therapy recommended by NICE for lymphoma
- JCVI recommends autumn COVID-19 vaccine booster for those at highest risk
- MIT researchers develop AI model to detect future lung cancer risk
- Merging global and local pharmacovigilance operations into a successful integrated approach
- Diversifying Healthcare AI with Federated Learning
- FDA and CDC investigate potential safety concern for Pfizer/BioNTech’s COVID-19 vaccine
- World Health Organization releases latest set of COVID-19 guidelines
- AbbVie and Eli Lilly leave UK’s voluntary drug pricing agreement
- EU to revise pharmaceuticals law amid antibiotic shortages
- European MPs call for urgent action against antimicrobial resistance
- The role of medical communications in building credibility for healthtech
PMHub
Onyx Health
Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national...
Latest intelligence
- Virtual Steering Committee & Peer Influence Program
- In this customer story, we describe the methodology and results of our client’s ongoing Virtual Steering Committee & Peer Influence program....
- Meeting healthcare’s rising challenges
- The journey to discover novel therapies through digital innovation and ensure scientific advances achieve their potential...
- Report gives insights to address gaps in HCP engagement
- How does Pharma-HCP engagement need to evolve in today's digital landscape?...
